These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9486935)

  • 21. Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studies.
    Sasaki M; Oki T; Iuchi A; Tabata T; Yamada H; Manabe K; Fukuda K; Abe M; Ito S
    J Hypertens; 1996 Dec; 14(12):1403-8. PubMed ID: 8986921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Influence of insertion-deletion polymorphism of the angiotensin converting enzyme gene on left ventricular hypertrophy in patients with aortic stenosis--differences in men and women].
    Orłowska-Baranowska E; Placha G; Gaciong Z; Zakrzewski D; Baranowski R; Kuśmierczyk-Droszcz B; Hoffman P; Rawczyńska-Englert I
    Pol Arch Med Wewn; 2002 Sep; 108(3):855-66. PubMed ID: 12600182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insertion/deletion polymorphism of angiotensin I converting enzyme gene and left ventricular hypertrophy in patients with type 2 diabetes mellitus.
    Moleda P; Majkowska L; Kaliszczak R; Safranow K; Adler G; Goracy I
    Kardiol Pol; 2006 Sep; 64(9):959-65; discussion 966. PubMed ID: 17054027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of the angiotensin converting enzyme I/D gene polymorphisms on left ventricular diastolic filling in patients with essential hypertension.
    Clarkson PB; Prasad N; MacLeod C; Burchell B; MacDonald TM
    J Hypertens; 1997 Sep; 15(9):995-1000. PubMed ID: 9321747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular risk factors, angiotensin-converting enzyme gene I/D polymorphism, and left ventricular mass in systemic hypertension.
    Celentano A; Mancini FP; Crivaro M; Palmieri V; Ferrara LA; De Stefano V; Di Minno G; de Simone G
    Am J Cardiol; 1999 Apr; 83(8):1196-200. PubMed ID: 10215283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Gene Polymorphism of Angiotensin-Converting Enzyme Intron Deletion and Angiotensin-Converting Enzyme G2350A in Patients With Left Ventricular Hypertrophy: A Meta-analysis.
    Fajar JK; Pikir BS; Sidarta EP; Berlinda Saka PN; Akbar RR; Heriansyah T
    Indian Heart J; 2019; 71(3):199-206. PubMed ID: 31543192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy.
    Iwai N; Ohmichi N; Nakamura Y; Kinoshita M
    Circulation; 1994 Dec; 90(6):2622-8. PubMed ID: 7994801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin-converting enzyme gene polymorphism and geometric patterns of hypertensive left ventricular hypertrophy.
    Ueno H; Takata M; Yasumoto K; Tomita S; Inoue H
    Jpn Heart J; 1999 Sep; 40(5):589-98. PubMed ID: 10888379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No correlation of polymorphism of angiotensin-converting enzyme genes with left ventricular hypertrophy in essential hypertension.
    Wu S; Hong J; Li H; Feng S; Qiao D; Gao M; Shi J; Nie H
    Hypertens Res; 2000 May; 23(3):261-4. PubMed ID: 10821136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy.
    Schunkert H; Hense HW; Holmer SR; Stender M; Perz S; Keil U; Lorell BH; Riegger GA
    N Engl J Med; 1994 Jun; 330(23):1634-8. PubMed ID: 8177269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensinogen gene M235T polymorphism predicts left ventricular hypertrophy in endurance athletes.
    Karjalainen J; Kujala UM; Stolt A; Mäntysaari M; Viitasalo M; Kainulainen K; Kontula K
    J Am Coll Cardiol; 1999 Aug; 34(2):494-9. PubMed ID: 10440164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haplotype of growth hormone and angiotensin I-converting enzyme genes, serum angiotensin I-converting enzyme and ventricular growth: pathway inference in pharmacogenetics.
    Huang S; Chen XH; Payne JR; Pennell DJ; Gohlke P; Smith MJ; Day IN; Montgomery HE; Gaunt TR
    Pharmacogenet Genomics; 2007 Apr; 17(4):291-4. PubMed ID: 17496728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Polymorphic markers I/D and G7831A of angiotensin-I-converting enzyme gene and left ventricular hypertrophy in patients with essential hypertension].
    Brazhnik VA; Gorashko NM; Minushkina LO; Zateĭshchikov DA; Zateĭshchikova AA; Nosikov VV; Sidorenko BA
    Kardiologiia; 2003; 43(2):44-9. PubMed ID: 12891272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Telomere length is associated with ACE I/D polymorphism in hypertensive patients with left ventricular hypertrophy.
    Fyhrquist F; Eriksson A; Saijonmaa O; Nordestgaard BG; Kontula K; de Faire U; Ibsen H; Kjeldsen S; Os I; Dahlöf B
    J Renin Angiotensin Aldosterone Syst; 2013 Sep; 14(3):227-34. PubMed ID: 23077078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of the I/D angiotensin-converting enzyme genotype for detecting the risk of left ventricular hypertrophy in pharmacologically treated hypertensive men.
    López-Contreras J; Blanco-Vaca F; Borrás X; Carreras F; Pons-Lladó G; Gallego F; Solé MJ; Cirera S; Benet MT; Negredo E; Roca-Cusachs A
    J Hum Hypertens; 2000 May; 14(5):327-31. PubMed ID: 10822320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass.
    Lindpaintner K; Lee M; Larson MG; Rao VS; Pfeffer MA; Ordovas JM; Schaefer EJ; Wilson AF; Wilson PW; Vasan RS; Myers RH; Levy D
    N Engl J Med; 1996 Apr; 334(16):1023-8. PubMed ID: 8598840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure.
    Andersson B; Sylvén C
    J Am Coll Cardiol; 1996 Jul; 28(1):162-7. PubMed ID: 8752809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ACE and angiotensinogen gene genotypes and left ventricular mass in athletes.
    Diet F; Graf C; Mahnke N; Wassmer G; Predel HG; Palma-Hohmann I; Rost R; Böhm M
    Eur J Clin Invest; 2001 Oct; 31(10):836-42. PubMed ID: 11737220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AT1 receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy.
    Osterop AP; Kofflard MJ; Sandkuijl LA; ten Cate FJ; Krams R; Schalekamp MA; Danser AH
    Hypertension; 1998 Nov; 32(5):825-30. PubMed ID: 9822439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy.
    Lechin M; Quiñones MA; Omran A; Hill R; Yu QT; Rakowski H; Wigle D; Liew CC; Sole M; Roberts R
    Circulation; 1995 Oct; 92(7):1808-12. PubMed ID: 7671365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.